Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders Biotech Investing
Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury Biotech Investing
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma Biotech Investing
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics Genetics Investing
VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101 Pharmaceutical Investing
Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology Biotech Investing
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder Pharmaceutical Investing
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis Pharmaceutical Investing
